Watch the Webinar
Please provide your details to gain access.
The Cell and Gene Therapy Catapult takes your data very seriously. By using this form you are consenting to the processing of your personal data as per ourprivacy policy.
This opportunity is now closed for applications but will reopen later in 2025. Please contact us if you are interested in this opportunity and want to be notified when it reopens.
Webinar description
Are you an academic group in Scotland developing an advanced therapy or vaccine? On behalf of and in collaboration with Scottish Enterprise, Cell and Gene Therapy Catapult's commercialisation experts are holding fully funded workshops where successful applicants will get one to one access to technical and clinical experts within their field. The initial in-person workshop and follow on support of up to four online calls over a 12-month period will aid the development of a bespoke target product profile (TPP) and action plan to optimise chances of successful technology development.
A TPP is a directional tool that needs to be developed from an early stage of a medicinal product’s development; it captures aspirational product attributes to steer the evidence generation plan, address regulatory and reimbursement requirements, aid development of strategies that reduce downstream risks and ultimately increase the probability of successful therapy adoption.
This webinar discusses the importance of a TPP for early-stage development, what we are offering to support academics in Scotland developing advanced therapies and vaccines, who is eligible, and how to apply for this opportunity.
Who should watch?
Academic groups in Scotland developing advanced therapies or vaccines are encouraged to attend.